Penumbra
PEN
#1687
Rank
$12.67 B
Marketcap
$322.32
Share price
-0.20%
Change (1 day)
14.84%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

EPS for Penumbra (PEN)

EPS in 2026 (TTM): $4.36

According to Penumbra's latest financial reports the company's current EPS (TTM) is $4.36. In 2025 the company made an earnings per share (EPS) of $4.55 an increase over its 2024 EPS that were of $0.37.

EPS history for Penumbra from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$4.36-4.18%
2025$4.551129.73%
2024$0.37
2022-$0.05790-138.6%
2021$0.15-134.09%
2020-$0.44-131.43%
2019$1.40636.84%
2018$0.1946.15%
2017$0.13-73.47%
2016$0.49432.67%
2015$0.09199

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Merit Medical
MMSI
$2.35-46.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Inari Medical
NARI
-$1.21-127.75%๐Ÿ‡บ๐Ÿ‡ธ USA